ABCC2 (ATP Binding Cassette Subfamily C Member 2)

This evidence demonstrates that maternal nutrition imbalance impairs fetal protection, with consequences for neurodevelopment. Optimizing maternal diet before and during pregnancy represents a strategy to reinforce placental and developing BBB function, safeguard the fetal brain, and improve long-term offspring health.

SIGNIFICANCE STATEMENT: Using novel bioengineered RNA agents, this study established the functional differences of 7 major human let-7-5p isoforms to control target gene expression and hepatocellular carcinoma cell viability in vitro. These findings demonstrate the potential of bioengineered RNA molecules to interrogate post-transcriptional gene regulation mechanisms, highlighting specific let-7-5p isoforms to modulate transporter and oncogene expression toward the development of improved therapies.

In conclusion, CDH17 promotes the expression and nuclear translocation of β-catenin in GC cells, leading to activation of the Wnt/β-catenin signaling pathway, which subsequently upregulates ABCB1/P-gp expression and enhances cellular capacity for DDP efflux. These findings imply that targeting CDH17 could be a potential strategy for overcoming chemotherapy resistance in GC.

5 prognosis-relevant LRGs could provide a novel perspective for the individualized therapeutic regimens for LUAD.

This study suggests potential future treatment strategies, with the possibility of increasing efficacy, reducing toxicity, and improving survival rates in pediatric oncology patients.

These findings highlight the utility of expanded analysis of routinely obtained NGS panel results at the time of CRC diagnosis at many medical centers to personalize the chemotherapy regimen. Our data suggest that patients who carry the ERCC1 rs11615 (A>G) variant may be protected from developing oxaliplatin-induced SOS and those lacking the G allele should be monitored more carefully after oxaliplatin use.

Furthermore, a significant association was found between ABCC2 c. 3972 C>T; rs3740066 and relapse in the recessive model [HR] 3.5, 95% CI 1.02-12.17, p = 0.04. Our findings indicate that ABCC1 r.5540 G>C SNV and ABCC2 c. 3972 C>T SNV are significant predictors of non-response and relapse in this group of pediatric patients with central nervous system tumors.

These findings underscore the necessity for molecular profiling in guiding the diagnosis and potential therapeutic strategies for RenNETs. Further studies are warranted to explore the mechanisms underlying their pathogenesis and clinical behavior.

The aim of this study was to determine the role and effect of OSM on the expression and activity of ABCC2 (cMOAT), an ABC transporter, in a hepatocellular carcinoma line (Hep G2) as an model. Our results suggest that this cytokine reduces expression of ABCC2 which may have potent consequences for the biliary transport.

Analysis of the expression of HML-2 and its association with CpG methylation contributes to a comprehensive interpretation of the CRC pathogenesis mechanisms.

The results showed that deoxypodophyllotoxin synthase (2-ODD), secoisolariciresinol dehydrogenase (SDH) and coumarate 3-hydroxylase (C3H) were essential genes that lead to the PTOX content differences in S. hexandrum from different provenances, WRKY and AP2/ERF-ERF were considered to be key transcription factors, and ABCE1 and ABCC2 were the primary transporters. The results can provide a new perspective and excellent genes for revealing the cause of the different PTOX contents in S. hexandrum from different provenances.

Overall, our findings showed that an adjustment of the initial asciminib dose may be needed based on genotyping information for the NR1I2 -25385C > T polymorphism and the body weight of the patient; however, further prospective studies are necessary.